Cassava Sciences
SAVA
#8913
Rank
A$0.21 B
Marketcap
A$4.40
Share price
-6.98%
Change (1 day)
1.91%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.22 Billion a decrease over its 2023 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-18.08%
2024 -A$0.22 Billion34.28%
2023 -A$0.16 Billion32.41%
2022 -A$0.13 Billion143.46%
2021 -A$49.38 Million383.92%
2020 -A$10.21 Million36.96%
2019 -A$7.45 Million-25.56%
2018 -A$10.01 Million-44.25%
2017 -A$17.95 Million-20.11%
2016 -A$22.47 Million5.32%
2015 -A$21.34 Million14.23%
2014 -A$18.68 Million-139.64%
2013 A$47.11 M
2010 -A$20.59 Million102.87%
2009 -A$10.15 Million-177.52%
2008 A$13.08 M-14.32%
2007 A$15.27 M-1942.21%
2006 -A$0.83 Million
2004 -A$58.53 Million75.1%
2003 -A$33.43 Million
2001 -A$26.02 Million20.49%
2000 -A$21.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.23 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA